Legal issues surrounding privately funded research cause furore in Toronto.
Toronto physician Miriam Shuchman has spent the last 4 months tracking the research issues surrounding a controversial clinical trial conducted in Toronto. Much of the information appearing in this article was gathered while she was preparing a segment for the CBC Radio program Quirks and Quarks. Earlier, she had reported on similar issues in the US for the Annals of Internal Medicine.
Shuchman
M
M
Department of Psychiatry, State University of New York, Buffalo, USA.
D035843:Biomedical Research; D002170:Canada; D002986:Clinical Trials as Topic / Q000191:economics* / Q000331:legislation & jurisprudence* / Q000592:standards; D016265:Conflict of Interest; D032982:Contracts; D000077543:Deferiprone; D030881:Disclosure; D015507:Drugs, Investigational / Q000009:adverse effects* / Q000627:therapeutic use; D006776:Hospitals, Pediatric; D006785:Hospitals, University; D006801:Humans; D033181:Information Dissemination; D007502:Iron Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology; D009864:Ontario; D011643:Publishing; D011728:Pyridones / Q000009:adverse effects* / Q000627:therapeutic use; D012109:Research Support as Topic / Q000331:legislation & jurisprudence*; D017211:Treatment Failure; D014342:Truth Disclosure; D017086:beta-Thalassemia / Q000150:complications*
D015507:Drugs, Investigational; D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone